The role of ramucirumab with docetaxel in epidermal growth factor receptor mutant and wild-type non-small cell lung cancer - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34527325/

Our data did not support the initial hypothesis that patients with EGFR mutant disease would do better with the addition of ramucirumab. Our study was limited by small sample size,...

Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated Metastatic EGFR-Mutated NSCLC: RELAY Japanese Subset - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34590023/

Clinically meaningful efficacy was observed with RAM + ERL versus PL + ERL in the RELAY Japanese subset, with no new safety concerns. Postprogression T790M rates were similar across treatment...

Driver gene alterations profiling of Chinese non-small cell lung cancer and the effects of co-occurring alterations on immunotherapy - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34599863/

doi: 10.1002/cam4.4178. Online ahead of print. 1 Medical Oncology Department, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China. 2 Training Department of Medical Service Department, General Hospital...

Trends in Molecular Testing of Lung Cancer in Mainland People's Republic of China Over the Decade 2010 to 2019 - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34590013/

In the decade 2010 to 2019, progress and increased capability of molecular testing of lung cancer were achieved in mainland People's Republic of China. Further efforts should address the clinical...

Current Landscape of Non-Small Cell Lung Cancer: Epidemiology, Histological Classification, Targeted Therapies, and Immunotherapy - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34572931/

Non-small cell lung cancer (NSCLC) is a subtype of the most frequently diagnosed cancer in the world. Its epidemiology depends not only on tobacco exposition but also air quality. While...